CYTK vs EWTX
Cytokinetics, Incorporated · Edgewise Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CYTK | EWTX |
|---|---|---|
| Price | $76.10 | $44.11 |
| Market Cap | $9.47B | $4.75B |
| P/E | — | — |
| P/B | — | 9.62 |
| P/S | 107.56 | — |
| ROE | — | -34.0% |
| Net Margin | -891.6% | — |
| Gross Margin | — | — |
| Revenue Growth | 376.6% | — |
| Dividend Yield | — | — |
| EPS | -$6.31 | -$1.56 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.